The UK has a proud record of innovation in healthcare and the deployment of innovations. Despite significant challenges, including workforce pressures and rising care demands, the NHS has the potential to lead in healthcare innovation. By leveraging the life sciences sector and rich health data, it can transform patient outcomes and the UK economy, provided decisive action is taken at all levels to overcome barriers.

The Innovation Ecosystem Programme has fostered collaboration between the NHS and key stakeholders, including industry, academia, and regulatory bodies to support this transformation. In our Innovation ecosystem report the programme provides comprehensive recommendations that will evolve the innovation ecosystem by testing, adopting, and scaling innovations for the benefit of patients and staff. The intention being to both develop a set of recommendations and define a collaborative way of working – solving problems together as well as agreeing and delivering plans for the future.

The Innovation Ecosystem Programme Advisory Group

• Roland Sinker CBE (Chair), Chief Executive of Cambridge University Hospitals NHS Foundation Trust and Cambridge Biomedical Campus, and National Director for Life Sciences, NHS England
• Dr Kristin-Anne Rutter, Executive Director, Cambridge University Health Partners, and the Cambridge Biomedical Campus
• Steve Bates OBE, Chief Executive Officer of the BioIndustry Association (BIA)
• Nicola Perrin MBE, Chief Executive of the Association of Medical Research Charities (AMRC)
• Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health and Social Care (DHSC)
• Dr Sam Roberts, Chief Executive of the National Institute for Health and Care Excellence (NICE)
• Rosalind Campion, Director of the Office for Life Sciences (OLS)
• Dame June Raine DBE, Chief Executive Officer of the Medicines and Healthcare products Regulatory Agency (MHRA)
• Dr Vinod Diwakar, National Director of Transformation, NHS England
• Verena Stocker, Director of Innovation, Research and Life Sciences Strategy, NHS England
• Peter Ellingworth, Chief Executive Officer of the Association of British HealthTech Industries (ABHI)
• Richard Stubbs, Chair, Health Innovation Network and Chief Executive, Health Innovation Yorkshire and Humber
• Professor Gary Ford CBE, Chief Executive Officer, Health Innovation Oxford and Thames Valley
• Dr Richard Torbett MBE, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI)
• Professor Dame Sue Hill, Chief Scientific Officer for England and SRO for NHS Genomics, NHS England
• Will Warburton, Managing Director of the Shelford Group
• Jacob Lant, Chief Executive of National Voices
• Will Field, Head of Policy, Innovation, Research and Life Sciences, NHS England

For further information contact england.innovation-ecosystem@nhs.net.